Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ·Healthcare·Biotechnology
$5.27
-6.65%
Mkt Cap $426.54M
Analyst Ratings
Buy
0
Hold
1
Sell
0
Price Target (2 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
+89.9%
Consensus $10.00 vs current $5.27
NASDAQ·Healthcare·Biotechnology
$5.27
-6.65%
Mkt Cap $426.54M
Buy
0
Hold
1
Sell
0
Price Target (2 analysts)
$10.00
Range $10.00 – $10.00
+89.9%
Consensus $10.00 vs current $5.27